Hexarelin vs Sermorelin
A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Hexarelin
Hexarelin is a potent synthetic hexapeptide GHRP (Growth Hormone-Releasing Peptide) that stimulates GH release via the ghrelin receptor. It produces among the highest GH pulses of any GHRP, but also elevates cortisol and prolactin — a trade-off that distinguishes it from more selective options like Ipamorelin.
Full profileSermorelin
Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH.
Full profile| Hexarelin | Sermorelin | |
|---|---|---|
| Category | Performance & Growth Hormone | Performance & Growth Hormone |
| Also known as | Examorelin, EP 23905, MF-6003 | GHRH 1-29, GRF 1-29 NH2, Geref |
| Evidence | Preclinical only | FDA-approved |
| Dosing range | 50mcg–200mcg mcg, 1–3x daily (cycling recommended to prevent desensitization) | 100mcg–500mcg mcg, once daily (before sleep) |
| Administration | Subcutaneous injection, Intramuscular injection | Subcutaneous injection |
| Key side effects | Cortisol elevation, Prolactin elevation, Water retention, Increased appetite | Injection site redness, Headache, Flushing, Dizziness |
| Cited sources | 1 reference | 1 reference |
Key differences
- Evidence level differs: Hexarelin is preclinical only, while Sermorelin is fda-approved.
- Administration: Hexarelin — Subcutaneous injection, Intramuscular injection; Sermorelin — Subcutaneous injection.
- Frequency: Hexarelin is typically 1–3x daily (cycling recommended to prevent desensitization); Sermorelin is once daily (before sleep).
How each works
Hexarelin
Hexarelin produces dose-dependent GH release significantly greater than GHRP-6 or Ipamorelin. It also has direct cardioprotective effects via CD36 receptor binding, independent of GH — making it unique among GHRPs. Studies show protection from ischemic cardiac injury and myocardial fibrosis reduction in animal models. Desensitization occurs with chronic continuous use.
Sermorelin
Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.